tirzepatide diabetes trial Effect of on Body Weight and Control in Adults With Type 1 Diabetes and Overweight or Obesity Tirzepatide Shows Superior Weight Loss

N Engl J Med 387(3):205216 Jastreboff AM, Kaplan LM, Frias JP et al (2023) Triple-hormone-receptor agonist retatrutide for obesitya phase 2 trial

Commonly observed effects in research include: Nausea Constipation Appetite suppression These are typically dose-dependent and reduce over time in long-duration studies

6 Diabetic Ketoacidosis (DKA, even with normal sugar) Stomach pain, nausea, rapid breathing, weakness

3 Remove & store Withdraw the pen straight out, unscrew the needle and discard it in an approved sharps container, then recap the reusable pen and return it to cool storage

Karacierden glukagon salgsn basklar